Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils

Nature Nanotechnology

Volumn 9, Issue 3, 2014, Pages 204-210

  Wang, Zhenjia ^a   Li, Jing ^a   Cho, Jaehyung ^a   Malik, Asrar B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BLOOD VESSELS; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; DISEASES; ENDOTHELIAL CELLS; NANOPARTICLES; PATHOLOGY;

ALBUMIN NANOPARTICLES; INFLAMMATORY DISEASE; INTRAVITAL MICROSCOPY; NANOPARTICLE TARGETING; POLYMORPHONUCLEAR NEUTROPHILS; SPLEEN TYROSINE KINASE; TUMOUR NECROSIS FACTOR ALPHAS; VASCULAR ENDOTHELIAL CELLS;

TARGETED DRUG DELIVERY;

ALBUMIN; CD18 ANTIGEN; FC RECEPTOR; NANOPARTICLE; PICEATANNOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM; INFLAMMATORY DISEASE; INTERNALIZATION; INTRAVITAL MICROSCOPY; LEUKOCYTE; MICROSCOPY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

ANIMALS; CATTLE; CELL ADHESION; DRUG CARRIERS; ENDOTHELIUM, VASCULAR; INFLAMMATION; MICE; NANOPARTICLES; NEUTROPHILS; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG; SERUM ALBUMIN, BOVINE; STILBENES;

EID: 84895919794     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2014.17     Document Type: Article

References (27)

1. Hu, G., Malik, A. B. & Minshall, R. D. Toll-like receptor 4 mediates neutrophil sequestration and lung injury induced by endotoxin and hyperinflation. Crit. Care Med. 38, 194-201 (2010
2. Tabas, I. & Glass, C. K. Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science 339, 166-172 (2013
3. Wang, Z., Tiruppathi, C., Cho, J., Minshall, R. D. & Malik, A. B. Delivery of nanoparticle: Complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life 63, 659-667 (2011
4. Xu, J. et al. Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating b2 integrins. Nature Immunol. 9, 880-886 (2008
5. Wong, C. H., Heit, B. & Kubes, P. Molecular regulators of leucocyte chemotaxis during inflammation. Cardiovasc. Res. 86, 183-191 (2010
6. Phillipson, M. & Kubes, P. The neutrophil in vascular inflammation. Nature Med. 17, 1381-1390 (2011
7. Wagner, D. D. & Frenette, P. S. The vessel wall and its interactions. Blood 111, 5271-5281 (2008
8. Lockwood, C. M. et al. Anti-Adhesion molecule therapy as an interventional strategy for autoimmune inflammation. Clin. Immunol. 93, 93-106 (1999
9. Sharar, S. R., Winn, R. K., Murry, C. E., Harlan, J. M. & Rice, C. L. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits. Surgery 110, 213-219 (1991
10. Petros, R. A. & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nature Rev. Drug Discov. 9, 615-627 (2010
11. Farokhzad, O. C. & Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 3, 16-20 (2009
12. Schroeder, A. et al. Treating metastatic cancer with nanotechnology. Nature Rev. Cancer 12, 39-50 (2012
13. Hahm, E. et al. Extracellular protein disulfide isomerase regulates ligand-binding activity of aMb2 integrin and neutrophil recruitment during vascular inflammation. Blood 121, 3789-3800 (2013
14. Hidalgo, A. et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nature Med. 15, 384-391 (2009
15. Evans, R., Lellouch, A. C., Svensson, L., McDowall, A. & Hogg, N. The integrin LFA-1 signals through ZAP-70 to regulate expression of high-Affinity LFA-1 on T lymphocytes. Blood 117, 3331-3342 (2011
16. Weber, C., Kreuter, J. & Langer, K. Desolvation process and surface characteristics of HSA-nanoparticles. Int. J. Pharm. 196, 197-200 (2000
17. Sumagin, R., Prizant, H., Lomakina, E., Waugh, R. E. & Sarelius, I. H. LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ. J. Immunol. 185, 7057-7066 (2010
18. Bull, H. B. & Breese, K. Interaction of alcohols with proteins. Biopolymers 17, 2121-2131 (1978
19. Wang, Z., Tiruppathi, C., Minshall, R. D. & Malik, A. B. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 3, 4110-4116 (2009
20. Chen, K. et al. Endocytosis of soluble immune complexes leads to their clearance by FcgRIIIB but induces neutrophil extracellular traps via FcgRIIA in vivo. Blood 120, 4421-4431 (2012
21. Indik, Z. K., Park, J. G., Hunter, S. & Schreiber, A. D. The molecular dissection of Fcg receptor mediated phagocytosis. Blood 86, 4389-4399 (1995
22. Zarbock, A., Lowell, C. A. & Ley, K. Spleen tyrosine kinase Syk is necessary for E-selectin-induced aLb2 integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26, 773-783 (2007
23. Geahlen, R. L. & McLaughlin, J. L. Piceatannol (3,4,3',5'- Tetrahydroxy-Transstilbene) is a naturally occurring protein-Tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 165, 241-245 (1989
24. Wisel, S. et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J. Pharmacol. Exp. Ther. 329, 543-550 (2009
25. Matthay, M. A. & Zemans, R. L. The acute respiratory distress syndrome: Pathogenesis and treatment. Annu. Rev. Pathol. 6, 147-163 (2011
26. Lo, S. K., Everitt, J., Gu, J. & Malik, A. B. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest 89, 981-988 (1992
27. Nakatani, K. et al. Regulation of the expression of Fcg receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin. Exp. Immunol. 117, 418-422 (1999